Article Details

Eliem Therapeutics (NASDAQ:ELYM) Research Coverage Started at HC Wainwright

Retrieved on: 2022-10-31 06:56:57

Tags for this article:

Click the tags to see associated articles and topics

Eliem Therapeutics (NASDAQ:ELYM) Research Coverage Started at HC Wainwright. View article details on hiswai:

Excerpt

Millennium Management LLC purchased a new stake in shares of Eliem Therapeutics during the 2nd quarter worth approximately $272,000.

Article found on: www.etfdailynews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up